Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Decrease in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) was the recipient of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 1,530,000 shares, a decrease of 56.0% from the December 15th total of 3,480,000 shares. Currently, 4.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 6,330,000 shares, the short-interest ratio is presently 0.2 days.

Cardio Diagnostics Trading Down 7.6 %

Shares of CDIO stock traded down $0.05 during trading hours on Tuesday, hitting $0.58. 601,689 shares of the company’s stock were exchanged, compared to its average volume of 1,485,239. Cardio Diagnostics has a 12-month low of $0.19 and a 12-month high of $2.83. The business’s 50 day simple moving average is $0.65 and its 200-day simple moving average is $0.46.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.